1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Fibroblast Growth Factor Receptor: new trials by email Literature Review of Fibroblast Growth Factor Receptor trials Research Report on Fibroblast Growth Factor Receptor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I BLASST-3 Trial Infigratinib - Bladder Transitional Cell Carcinoma, Bladder Cancer | Phase 1 | Withdrawn | Guru P. Sonpavde | 2021-12-23 | 2022-08-10 |
Acrocephalosyndactylia (1) · Urinary Bladder Neoplasms (1)
Bone Diseases (1) · Bone Diseases, Developmental (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Craniofacial Abnormalities (1) · Craniosynostoses (1) · Dysostoses (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Limb Deformities, Congenital (1) · Male Urogenital Diseases (1) · Musculoskeletal Abnormalities (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Site (1)
infigratinib (1)
Guru P. Sonpavde (1)